Not medical advice. I am a software engineer, not a physician. This page documents my own protocol and the research I read while building it. Talk to a qualified clinician before changing your supplementation, diet or any treatment. Lab reference ranges quoted here vary by laboratory and by individual.
Affiliate disclosure: the iHerb links on this page carry a referral code and pay me a commission if you buy. It does not change your price, and I do not link anything I do not use myself.
The reproductive and hormonal system governs far more than fertility. Testosterone, estrogen, DHEA, and their metabolites regulate muscle mass, bone density, fat distribution, mood, cognitive function, cardiovascular health, and libido. In men, testosterone levels have been declining at approximately 1% per year since the 1980s across all age groups — a trend attributed to environmental endocrine disruptors, obesity, poor sleep, and chronic stress.
Hormonal optimization does not necessarily mean hormone replacement therapy (HRT). In many cases, correcting underlying issues — vitamin D deficiency, zinc depletion, sleep deprivation, excess body fat, and chronic stress — can meaningfully improve hormonal profiles. Lab testing is essential to identify which specific hormones are out of balance and guide targeted interventions.
The HPG axis feedback loop: The hypothalamus releases GnRH, which stimulates the pituitary to secrete LH and FSH. LH drives testosterone production in the testes (Leydig cells), while FSH supports spermatogenesis (Sertoli cells). Testosterone feeds back to suppress GnRH and LH. Disruption at any level — hypothalamus (stress, sleep), pituitary (prolactin excess), or gonadal (primary hypogonadism) — impairs the entire cascade.
Hormonal balance requires coordinated signaling across the hypothalamic-pituitary-gonadal (HPG) axis, proper aromatase regulation, and healthy SHBG levels. Understanding these mechanisms reveals why specific supplements and lifestyle interventions work.
Lopresti, A. L., et al. (2019). A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha (KSM-66) in Aging, Overweight Males. Am J Mens Health, 13(2). PubMed 30854916
These supplements work through different mechanisms: HPA axis modulation (cortisol reduction), LH stimulation, estrogen metabolism optimization, and direct hormonal cofactors.
| Supplement | Role | Timing | Details |
|---|---|---|---|
| Ashwagandha (KSM-66) | Reduces cortisol 27-30%; increases testosterone 10-22% in stressed men | 600 mg/day (300 mg 2x/day with meals) | Ashwagandha |
| Tribulus Terrestris | May support LH release; most effective in men with suboptimal levels | 750-1500 mg/day standardized to 45% saponins | Tribulus |
| DIM (Diindolylmethane) | Promotes favorable estrogen metabolism; reduces estrogenic activity | 100-200 mg/day with meals | DIM |
| Zinc (Picolinate or Bisglycinate) | Direct cofactor for testosterone synthesis; deficiency drops T by up to 75% | 15-30 mg/day with meals | Zinc Picolinate |
| Saw Palmetto | Inhibits 5-alpha reductase; reduces DHT for prostate and hair protection | 320 mg/day standardized extract | Saw Palmetto |
| Vitamin D3 | Men with 25-OH-D >50 ng/mL have significantly higher T than those <20 ng/mL | 2000-5000 IU/day with fat | Vitamin D3 + K2 |
Fix the foundations first: Before considering any testosterone-boosting supplement, address the four biggest T killers: (1) Sleep deprivation (4.5 hours/night reduces T by 10-15%), (2) Excess body fat (adipose aromatase converts T to estradiol), (3) Chronic stress (cortisol directly suppresses GnRH), and (4) Zinc deficiency (cofactor for T synthesis). These interventions alone can raise T by 20-40%.
A complete hormonal panel reveals not just testosterone levels but the entire regulatory cascade. Interpreting these tests together — not in isolation — is essential for accurate diagnosis and targeted treatment.
| Test | What It Measures | Frequency | Details |
|---|---|---|---|
| Total Testosterone | Total circulating testosterone (bound + free); optimal 500-900 ng/dL for men | Every 6-12 months (fasting, 7-10 AM) | Lab Tests |
| Free Testosterone | Bioavailable fraction; the testosterone that activates androgen receptors | Every 6-12 months | Lab Tests |
| Estradiol (E2) | Primary estrogen; elevated in men with excess aromatase activity or body fat | Every 6-12 months | Lab Tests |
| LH / FSH | Pituitary hormones; distinguish primary (gonadal) from secondary (pituitary/hypothalamic) hypogonadism | Every 12 months | Lab Tests |
| SHBG (Sex Hormone Binding Globulin) | Binds testosterone, reducing bioavailability; elevated SHBG can mask adequate total T | Every 12 months | Lab Tests |
| Prolactin | Elevated prolactin suppresses GnRH; can indicate pituitary adenoma or medication effects | Every 12 months (if symptoms present) | Lab Tests |
| DHT (Dihydrotestosterone) | Most potent androgen; drives hair loss and prostate growth; elevated with high 5-alpha reductase activity | Every 12 months (if clinically relevant) | Lab Tests |
SHBG is the invisible hormone thief: SHBG binds testosterone tightly, making it unavailable to tissues. A man with total T of 600 ng/dL but SHBG of 80 nmol/L may have less bioavailable testosterone than a man with total T of 400 ng/dL and SHBG of 20 nmol/L. Always request free testosterone or calculate it from total T and SHBG. Common causes of elevated SHBG: aging, hyperthyroidism, low-carb diets, and liver disease.
FDA eases testosterone safety restrictions after TRAVERSE trial. The landmark TRAVERSE trial provided definitive cardiovascular safety data, showing no increased risk of major heart events in men receiving testosterone replacement therapy. This led the FDA to remove its black box cardiovascular warning in 2025, and in December 2025, an FDA expert panel recommended further easing restrictions. The EAU Sexual and Reproductive Health Guidelines (2026 update) and the Fifth International Consultation on Sexual Medicine (ICSM 2024) now recommend comprehensive laboratory panels including free testosterone, sex hormone-binding globulin (SHBG), and inflammatory biomarkers for improved evaluation, along with modern delivery options including subcutaneous protocols.
Anti-obesity medications normalize testosterone in obese men. Research presented at ENDO 2025 demonstrated that GLP-1 receptor agonists and other anti-obesity medications can significantly raise testosterone levels and improve reproductive health outcomes in men with obesity or type 2 diabetes. This represents a novel therapeutic approach: rather than directly replacing testosterone, treating the underlying metabolic dysfunction with weight loss medications restores endogenous testosterone production, with the added benefit of preserving fertility — unlike exogenous testosterone, which suppresses spermatogenesis.